-
What We Know – and Don’t Know – About Zika and Its Treatment
Researchers all over the world are working on a vaccine for Zika but it will probably be next year, and possibly much longer, before health officials can determine whether a vaccine works or not. Meanwhile, with pathogens and their vectors moving farther and faster than ever before, it’s just a matter of time before Zika reaches many more parts of the world.
- Categories
- Health Care
-
New Ebola Vaccine Trial Results Offer Hope
A new Ebola vaccine may be the first to successfully protect against one of the world’s most lethal pathogens, according to a trial involving over 11,000 participants in Guinea.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
GSK Opens Global Vaccine Center in Rockville, MD
GlaxoSmithKline (GSK) today will officially open its newest global vaccines R&D center in Rockville, MD, where the pharma giant will base 450 researchers and support staffers and spend $50 million over the next 2 years on technology and equipment.
- Categories
- Health Care
- Region
- North America
-
The key to fighting the next ‘Ebola’ outbreak is in your pocket
When a toddler called Emile Ouamouno, in the village of Meliandou in Guinea, died from Ebola in December 2013, it took three months for the rest of the world to know about it and a further six months to act. The result was an epidemic that killed 11,000 people across West Africa.
- Categories
- Health Care
-
A Zika vaccine is being developed at warp speed, but will there be a market for it?
When top US health authorities convened in late January to brief President Barack Obama on the Zika outbreak in Latin America, the post-meeting scuttlebutt was that the president was eager to push development of a Zika vaccine.
- Categories
- Health Care
- Region
- North America
-
A method for storing vaccines at room temperature
Shipping vaccines in an unbroken temperature-controlled supply chain (a "cold chain") all the way to recipients is a major logistical and financial challenge in remote areas and developing countries. According to Doctors Without Borders, the need to keep vaccines within a temperature range of 2-8°C is one of the main factors behind low immunization-coverage rates.
- Categories
- Health Care
- Tags
- public health, vaccines
-
HIV Vaccine Trial to Begin in South Africa
A new clinical trial is underway in South Africa on an experimental vaccine that could safely prevent HIV, the virus that causes AIDS. According to a statement from the National Institutes of Health (NIH), the HVTN 702 is the largest and most advanced HIV vaccine clinical trial to be undertaken in South Africa, where some seven million people are living with the virus.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health, research, vaccines
-
FG, GSK Freeze Price of Pneumonia Vaccines for Next 10 Years
The federal government in conjunction with a leading pharmaceutical company, GSK, has pledged not to increase the price of pneumonia vaccines for the next 10 years but to rather freeze the price for improved vaccination. The plan, according to the company, would ensure that children in the country do not die of the disease, which is now the number one killer disease amongst children under five.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.